Table 3.
Number of economic evaluations by health area and income group
| Income group studied | |||||
|---|---|---|---|---|---|
| Health area | Low | Lower‐middle | Upper‐middle | High | World |
| Cancer and other neoplasms | 7 | 8 | 73 | 416 | 492 |
| Cardiovascular diseases | 3 | 7 | 44 | 448 | 490 |
| Mental health, cognition, and developmental and behavioural disorders (including self‐harm and substance disorders) | 1 | 10 | 21 | 243 | 268 |
| Musculoskeletal diseases (including back pain) | 2 | 3 | 18 | 240 | 262 |
| Respiratory diseases | 6 | 8 | 39 | 188 | 228 |
| Genitourinary diseases, contraception & fertility | 4 | 4 | 18 | 180 | 203 |
| Other infectious diseases (including encephalitis, hepatitis, other parasitic and vector‐borne diseases, and nematode infections) | 6 | 10 | 38 | 111 | 159 |
| Digestive disorders | 3 | 3 | 21 | 127 | 152 |
| Neonatal and maternal conditions | 17 | 7 | 23 | 102 | 142 |
| HIV/AIDS | 31 | 27 | 46 | 61 | 136 |
| Diabetes | 1 | 3 | 22 | 102 | 125 |
| Malnutrition (including obesity and exercise) | 6 | 4 | 9 | 98 | 113 |
| Wounds and injuries (including violence) | 4 | 7 | 13 | 91 | 109 |
| Endocrine, blood, and immune disorders (excluding diabetes or HIV) | 0 | 1 | 12 | 86 | 99 |
| Neurological conditions | 1 | 3 | 16 | 81 | 98 |
| Skin and oral conditions | 0 | 3 | 5 | 67 | 75 |
| Sense organ diseases | 2 | 3 | 11 | 56 | 68 |
| Tuberculosis | 8 | 9 | 28 | 34 | 62 |
| Sexually transmitted diseases (excluding HIV) | 2 | 1 | 10 | 39 | 49 |
| Diarrhoeal diseases | 6 | 7 | 9 | 29 | 46 |
| Communicable childhood diseases | 2 | 5 | 9 | 24 | 40 |
| Malaria | 16 | 13 | 8 | 1 | 24 |
| Congenital anomalies | 0 | 1 | 2 | 20 | 23 |
| Anaemia | 0 | 1 | 1 | 9 | 11 |
| Meningitis | 2 | 2 | 3 | 3 | 9 |
| TOTAL | 104 | 120 | 390 | 2337 | 2829 |
A single economic evaluation may address more than one health area in countries of more than one income group. The totals exclude the 15 articles (0.5%) in our data set which could not be classified by health area.